1
/
of
1
Elabscience
SKU:PKSH034050
Recombinant Human IL-1 Receptor Accessory Protein/IL-1RAcP/IL-1R3 (C-6His)
Recombinant Human IL-1 Receptor Accessory Protein/IL-1RAcP/IL-1R3 (C-6His)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS), a cutting-edge product designed to revolutionize the field of immunology. This meticulously engineered protein offers unparalleled functionality and versatility, making it an indispensable tool for researchers and scientists alike.
The Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) boasts a superior level of purity and stability, ensuring consistent and reliable results in a wide range of applications. Its unique composition enables precise and efficient binding to the IL-1 receptor, facilitating the study of various cellular processes and signaling pathways.
Crafted with utmost precision, this product exhibits exceptional bioactivity, enabling researchers to delve into the intricate mechanisms underlying immune responses. Its recombinant nature ensures a high degree of consistency and reproducibility, eliminating any concerns regarding batch-to-batch variability.
Furthermore, the inclusion of a C-6HIS tag enhances the ease of purification and detection, streamlining experimental procedures and saving valuable time and resources. This feature enables researchers to focus on their core objectives, accelerating the pace of scientific discovery.
The Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. This guarantees the utmost purity, integrity, and functionality of the product, ensuring optimal performance and reproducibility in every experiment.
In summary, the Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) represents a groundbreaking advancement in the field of immunology. Its exceptional purity, stability, and bioactivity, coupled with the convenience of the C-6HIS tag, make it an indispensable tool for researchers seeking to unravel the complexities of immune responses. Embrace this cutting-edge product and unlock new frontiers in immunological research.
The Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) boasts a superior level of purity and stability, ensuring consistent and reliable results in a wide range of applications. Its unique composition enables precise and efficient binding to the IL-1 receptor, facilitating the study of various cellular processes and signaling pathways.
Crafted with utmost precision, this product exhibits exceptional bioactivity, enabling researchers to delve into the intricate mechanisms underlying immune responses. Its recombinant nature ensures a high degree of consistency and reproducibility, eliminating any concerns regarding batch-to-batch variability.
Furthermore, the inclusion of a C-6HIS tag enhances the ease of purification and detection, streamlining experimental procedures and saving valuable time and resources. This feature enables researchers to focus on their core objectives, accelerating the pace of scientific discovery.
The Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures. This guarantees the utmost purity, integrity, and functionality of the product, ensuring optimal performance and reproducibility in every experiment.
In summary, the Recombinant Human IL-1 Receptor Accessory Protein/IL-1RACP/IL-1R3 (C-6HIS) represents a groundbreaking advancement in the field of immunology. Its exceptional purity, stability, and bioactivity, coupled with the convenience of the C-6HIS tag, make it an indispensable tool for researchers seeking to unravel the complexities of immune responses. Embrace this cutting-edge product and unlock new frontiers in immunological research.
Share
